Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 51655-881

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 51655-881). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (51655 881 30 Rev A 07 22)

Label (51655 881 30 Rev A 07 22)
This is a description of a bottle of Atorvastatin Calcium Tablets, USP at a strength of 80mg, containing 30 tablets. The medication is only available with a prescription and should be stored at a temperature between 20°C-25°C. Each tablet has a film coating and contains Atorvastatin Calcium equivalent to 80mg of Atorvastatin. It is repackaged by Northwind Pharmaceuticals and has a GTIN of 00351655881309. Lot number is 0000000000, and expiration date is 00/00/0000.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
The text describes the cumulative hazard percentage over a four-year follow-up period of a drug called Atorvastatin. The hazard ratio (HR) is given as 0.53 with a confidence interval of 0.45-0.83. However, the has not recognized the full text and some parts are unclear.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
The given text seems to be a table reporting the percentage of subjects experiencing E vert, with two different types of drugs - Horvastatin (10 mg) and Sorvastatin (80 mg). It also mentions a HR (Hazard Ratio) and a P-value. The table seems to depict the Time to First Major Cardiovascular Endpoint in years. Therefore, based on the available information, it can be inferred that this table provides information on the efficacy of these two drugs in treating cardiovascular diseases.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.